Skip to content

Auricular electroacupuncture based on MRI brain imaging and intestinal flora in the treatment of depression and gut-brain axis mechanism and prediction of efficacy

Auricular electroacupuncture based on MRI brain imaging and intestinal flora in the treatment of depression and gut-brain axis mechanism and prediction of efficacy

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2200005972
Enrollment
Unknown
Registered
2022-05-04
Start date
2022-05-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

depression

Interventions

taVNS group:taVNS?
sham taVNS group:?taVNS?

Sponsors

Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: (1) Meet the ICD-10 classification criteria for moderate-to-mild (2 core symptoms + 2 accompanying symptoms), moderate (2 core symptoms + 3-4 accompanying symptoms) depression classification criteria; (2) The disease duration ranges from 2 weeks to 7 points in 2 years = HAMD-17 score = 24 points; (3) The age is between 18 and 70 years old, and the gender is not limited; (4) The education level is above junior high school, and can understand the content of the scale and cooperate with the research; (5) Volunteered to participate in this study and signed the informed consent.

Exclusion criteria

Exclusion criteria: (1) Patients with severe depression, or patients with severe mental illness, such as schizophrenia, mania, and those with obvious suicidal tendencies; (2) Depressive disorders caused by psychoactive substances or non-addictive substances; (3) Patients with Patients with organic brain diseases; (4) patients with serious physical diseases, such as heart disease, tumors or organic lesions of the central nervous system; (5) patients with other neurological diseases, such as epilepsy, Parkinson's disease (6) Pregnant or breastfeeding women; (7) Those with low compliance or unable to adhere to treatment for other reasons; (8) Those who are allergic to the study drug or have contraindications to fMRI scanning; (9) Those who did not sign the informed consent form.

Design outcomes

Primary

MeasureTime frame
Hamilton Anxiety Scale (HAMA-14);Hamilton Depression Scale (HAMD-17);

Countries

CHINA

Contacts

Public ContactFang Jiliang

Guang'anmen Hospital, China Academy of Chinese Medical Sciences, No. 5 Beixian Pavilion, Xicheng District, Beijing

fangmgh@163.com13683338202

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026